ROR1 and neoplasm: demonstrated that oxaliplatin can activate macrophages to express T cells–recruiting chemokines, promote ROR1-CAR T cells infiltration into the tumor core, and restore tumor sensitivity to αPD-L1 therapy, resulting in durable antitumor effects (141).